Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"
04-21 Vapotherm Announces Fda 510(K) Clearance for the All Patient Circuit, Enabling High Velocity Therapy for Neonatal to Adult Patients CI
12-08 Vapotherm, Inc. and Flight Medical Innovations Ltd. Announce Partnership to Bring the VentO2ux?? Ventilator to US Hospitals CI
25-05-20 Vapotherm, Inc. Announces New Study Confirms its Unicorn Cannula Provides Comparable Efficacy at Lower Flow Rates CI
24-09-19 Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC completed the acquisition of Vapotherm, Inc. from a group of shareholders. CI
24-08-12 Vapotherm, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-06-16 Vapotherm, Inc. announced that it expects to receive $50 million in funding from Perceptive Advisors LLC CI
24-06-16 Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC entered into definitive merger agreement to acquire Vapotherm, Inc. for $15.1 million. CI
24-05-09 Vapotherm, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-04-01 Vapotherm, Inc. Enters into Amendment No. 7 to Loan and Security Agreement with SLR Investment Corp CI
24-03-15 Vapotherm, Inc. to Unveil Access365 Home Ventilation Solution at MEDTRADE CI
24-02-22 Vapotherm, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
24-02-22 Vapotherm, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
24-02-21 Vapotherm, Inc. Auditor Raises 'Going Concern' Doubt CI
Manager TitleAgeSince
Chief Executive Officer 62 2012-06-25
Chief Tech/Sci/R&D Officer - 2022-01-31
Comptroller/Controller/Auditor 44 2021-12-05
Director TitleAgeSince
Director/Board Member 42 2024-09-19
Date Insider Type Main position Quantity % Market Cap.
24-09-19Issuer sale

Chief Executive Officer

498,938 7.9895%
24-09-19Issuer sale

Controller/Auditor

26,696 0.4275%
24-09-19Issuer sale

Director

101,377 1.6233%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%+0.46% - - 13.59M
-1.08%-2.97%+14.85%-13.00% 173B
-1.30%-3.82%-22.22%+22.29% 144B
-0.79%-3.19%-10.71%-25.83% 125B
-2.58%-5.57%-56.86%-19.19% 67.32B
-1.83%-0.44%+14.05%-5.95% 50.3B
+0.72%-1.49%-26.02%-32.02% 43.8B
-0.78%-3.32%+8.72%+6.39% 35.89B
-0.38%-0.42%+3.92%+36.88% 34.9B
-1.54%-6.63%-15.03%-24.62% 28.02B
Average -1.00%-1.86%-9.92%-6.12% 78.04B
Weighted average by Cap. -1.13%-1.89%-8.84%-6.32%
Logo Vapotherm, Inc.
Vapotherm, Inc. is a developer and manufacturer of advanced respiratory technology. It develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. It is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.
Employees
182
  1. Stock Market
  2. Stocks
  3. VAPO Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!